Current price is less than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

Returns vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a mid-cap company (with a market cap of Rs 14826.53 crore) operating in pharmaceuticals sector.

Buy Glenmark Pharma, target price Rs 560: Yes Securities

Glenmark Pharmaceuticals Ltd is quoting at Rs 530, up 1.97% on the day as on 12:54 IST on the NSE. The stock is up 13.03% in last one year as compared to a 34.53% gain in NIFTY and a 14.62% gain in the Nifty Pharma index.

Glenmark Pharmaceuticals Ltd jumps around 2%

Glenmark Pharmaceuticals Ltd spurts 1.97%, up for third straight session

Here’s what Mazhar Mohammad of chartviewindia.in, recommends investors should do with these stocks when the market resumes trading today.

Trade Spotlight | What Should You Do With Glenmark Pharma, Navin Fluorine, Raymond & Birlasoft Stocks?

#CNBCAwaazLive #BusinessNewsLive #GlenmarkPharma   #GlenmarkPharmaStock  #StockMarket #ShareMarketToday

Glenmark Pharma में नजर आई बढ़िया तेजी। बता दे की, Expert ने इस Stock के लिए दी है Avoid की सलाह? इस Stock के अब तक के Performance को जानते हुए Expert  ने दी है सटीक  राय. देखें वीडियो. 


Share Market से जुडी हर खबर सबसे पहले, CNBC Awaaz पर मिलेगा आपको बढ़िया कमाई का मौका.  यहाँ दिग्गजों के साथ करें कमाई और घर बैठे पाएं Best Trading Ideas के साथ-साथ बिसनेस की दुनिया से जुडी सारी अहम खबरें. 


Share Market से जुड़ी हर छोटी या बड़ी खबर, चाहे हो Nifty में आए नए हाई या फिर, हो आपके के लिए स्टॉक्स पर राय, बिजनेस न्यूज हो या पॉलिटिकल न्यूज, कोरोनावायरस की न्यूज हो या फिर इलेक्शन, देखें CNBC Awaaz और रहे हर खबर से updated.


CNBC Awaaz is India’s number one business channel and an undisputed leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence.

Subscribe to the CNBC Awaaz YouTube channel here: https://tinyurl.com/y5rsvesk

Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz
Like us on our CNBC Awaaz Facebook page: https://www.facebook.com/cnbcawaaz

Glenmark Pharma में नजर आई बढ़िया तेजी, लेकिन Expert ने क्यों दी है Avoid की सलाह? | Markets Today

Glenmark Pharmaceuticals Ltd, Aptech Ltd, Gateway Distriparks Ltd and NRB Bearings Ltd are among the other gainers in the BSE’s ‘A’ group today, 23 November 2021.

Raymond Ltd leads gainers in ‘A’ group

The stable outlook reflects our view that Glenmark will maintain its financial policy such that its FFO-to-debt ratio will remain comfortably above 30%.

S&P Global Ratings upgrades Glenmark Pharma to BB on expected maintenance of lower leverage

Geojit recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 575 in its research report dated November 18, 2021.

Accumulate Glenmark Pharmaceuticals Target Of Rs 575: Geojit

Over 800 companies across sectors from the emerging markets were assessed, out of which around 108 made it to the prestigious index this year including 15 from India.

Glenmark Pharma makes it to Dow Jones Sustainability Emerging Markets Index for 4th year in a row

Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 560 in its research report dated November 15, 2021.

Neutral Glenmark Pharma; Target Of Rs 560: Motilal Oswal

Prabhudas Lilladher recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 600 in its research report dated November 16, 2021.

Accumulate Glenmark Pharmaceuticals; Target Of Rs 600: Prabhudas Lilladher

Glenmark Pharmaceuticals Limited is a global pharmaceutical company engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Glenmark Pharma, target price Rs 560: Yes Securities

Glenmark Pharmaceuticals Ltd jumps around 2%

Glenmark Pharmaceuticals Ltd spurts 1.97%, up for third straight session

Trade Spotlight | What Should You Do With Glenmark Pharma, Navin Fluorine, Raymond & Birlasoft Stocks?

News Video

Glenmark Pharma में नजर आई बढ़िया तेजी, लेकिन Expert ने क्यों दी है Avoid की सलाह? | Markets Today

Raymond Ltd leads gainers in ‘A’ group

S&P Global Ratings upgrades Glenmark Pharma to BB on expected maintenance of lower leverage

Glenmark Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Glenmark Pharma, target price Rs 560: Yes Securities

Glenmark Pharmaceuticals Ltd jumps around 2%

Glenmark Pharmaceuticals Ltd spurts 1.97%, up for third straight session

Trade Spotlight | What Should You Do With Glenmark Pharma, Navin Fluorine, Raymond & Birlasoft Stocks?

News Video

Glenmark Pharma में नजर आई बढ़िया तेजी, लेकिन Expert ने क्यों दी है Avoid की सलाह? | Markets Today

Raymond Ltd leads gainers in ‘A’ group

S&P Global Ratings upgrades Glenmark Pharma to BB on expected maintenance of lower leverage

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock